NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

HPGC Renmintongtai Pharmaceutical Corporation (SHG: 600829)

 
600829 Technical Analysis
4
As on 31st Jul 2025 600829 STOCK Price closed @ 8.28 and we RECOMMEND Buy for LONG-TERM with Stoploss of 6.42 & Strong Buy for SHORT-TERM with Stoploss of 6.49 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

600829STOCK Price

Open 8.52 Change Price %
High 8.58 1 Day -0.49 -5.59
Low 8.28 1 Week -1.22 -12.84
Close 8.28 1 Month 1.11 15.48
Volume 38814712 1 Year 1.42 20.70
52 Week High 10.25 | 52 Week Low 5.19
 
SHG China Most Active Stocks
600010 2.69 -7.88%
601162 5.32 2.70%
600705 3.47 0.29%
600811 0.36 -2.70%
601669 6.83 0.44%
600157 1.43 -2.72%
600221 1.48 -3.90%
601360 11.30 6.20%
601288 6.30 1.12%
600117 4.46 6.19%
 
SHG China Top Gainers Stocks
688189 17.14 20.03%
600462 0.21 10.53%
603229 11.61 10.05%
603839 9.44 10.02%
603757 26.13 10.02%
600110 6.26 10.02%
603063 37.90 10.01%
600774 11.33 10.00%
600501 23.77 10.00%
603516 60.48 10.00%
 
SHG China Top Losers Stocks
603669 6.27 -10.04%
600977 13.28 -9.97%
601001 13.06 -9.37%
601929 1.94 -9.35%
600010 2.69 -7.88%
600569 2.34 -7.51%
600307 1.76 -6.88%
600408 2.32 -6.83%
600804 0.14 -6.67%
600438 20.43 -6.50%
 
 
600829
Daily Charts
600829
Intraday Charts
Whats New @
Bazaartrend
600829
Free Analysis
 
600829 Important Levels Intraday
RESISTANCE8.86
RESISTANCE8.67
RESISTANCE8.56
RESISTANCE8.44
SUPPORT8.12
SUPPORT8.00
SUPPORT7.89
SUPPORT7.70
 
600829 Forecast August 2025
4th UP Forecast13.43
3rd UP Forecast11.78
2nd UP Forecast10.76
1st UP Forecast9.74
1st DOWN Forecast6.82
2nd DOWN Forecast5.8
3rd DOWN Forecast4.78
4th DOWN Forecast3.13
 
600829 Weekly Forecast
4th UP Forecast12.52
3rd UP Forecast11.16
2nd UP Forecast10.32
1st UP Forecast9.48
1st DOWN Forecast7.08
2nd DOWN Forecast6.24
3rd DOWN Forecast5.40
4th DOWN Forecast4.04
 
600829 Forecast2025
4th UP Forecast20.46
3rd UP Forecast16.55
2nd UP Forecast14.14
1st UP Forecast11.72
1st DOWN Forecast4.84
2nd DOWN Forecast2.42
3rd DOWN Forecast0.01
4th DOWN Forecast-3.9
 
 
600829 Other Details
Segment EQ
Market Capital 3282171904.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
600829 Address
600829
 
600829 Latest News
 
Your Comments and Response on HPGC Renmintongtai Pharmaceutical Corporation
 
600829 Business Profile
HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, blood purification, and renal disease treatment. In addition, the company offers Chinese and Western medicines, Chinese herbal medicines, nourishing health care products, medical equipment, cosmetics, and daily necessities through an e-commerce platform. It operates 319 chain stores in Heilongjiang Province. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd. Address: 418 Harbin Road, Harbin, China, 150071
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service